Skip to main content
Caplight Logo









ChartPath

ChartPath

Private
Austin, TexasHealthcare & Life Scienceshttps://chartpath.com

Company Overview

ChartPath operates in Healthcare & Life Sciences and is based in Austin, Texas. It was founded in 2012.

ChartPath is a healthcare technology company that provides electronic health record (EHR) and revenue cycle management (RCM) software solutions for long-term and post-acute care (LTPAC) practices.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Revenue Cycle, Vertical SaaS, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

ChartPath Comparables

Compare ChartPath with similar companies based on industry and business-model similarity.

ChartPath comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Saisystems International
85%
DocNow
83%
PointClickCare
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

ChartPath Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for ChartPath. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Kevin Oliver

Chief Technology Officer

Executive Team

Brian Entrekin

COO

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 38% MoM.

  • Apr 23, 2026

    Monthly visitors increased 141% to 17.6K.

Book a demo to see all signals

For institutional investors. Book with your work email.

ChartPath Filings

Explore SEC and related filing metadata, where available.

ChartPath filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about ChartPath's valuation, stock price, and market status.

Is ChartPath a public or private company?

ChartPath is a private company.

What is the current stock price of ChartPath?

ChartPath is a private company, so its shares have no public market price. Caplight tracks ChartPath's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is ChartPath worth (valuation)?

Valuation information for ChartPath is not publicly available.

Can I buy ChartPath stock?

ChartPath shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was ChartPath's last funding round?

Funding round information for ChartPath is not publicly available.

Who are the main investors in ChartPath?

Investor information for ChartPath is not publicly disclosed.

Will ChartPath IPO soon?

No public IPO plans have been announced for ChartPath.

How can I track ChartPath secondary market activity?

Caplight tracks bids, offers, and trades in ChartPath's shares on secondary markets.

Firmographic Details

HeadquartersAustin, Texas
Employee Range8
Year Founded2012
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?